CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 134 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $383,000 | +78.1% | 195,480 | +366.1% | 0.02% | +72.7% |
| Q3 2019 | $215,000 | -64.5% | 41,939 | -50.3% | 0.01% | -67.6% |
| Q2 2019 | $605,000 | -17.9% | 84,439 | +52.1% | 0.03% | -22.7% |
| Q1 2019 | $737,000 | +667.7% | 55,516 | +354.5% | 0.04% | +633.3% |
| Q4 2018 | $96,000 | -84.5% | 12,216 | -78.1% | 0.01% | -78.6% |
| Q3 2018 | $618,000 | -17.4% | 55,815 | -3.2% | 0.03% | -6.7% |
| Q1 2018 | $748,000 | +434.3% | 57,631 | +278.4% | 0.03% | +400.0% |
| Q4 2017 | $140,000 | +44.3% | 15,231 | -57.8% | 0.01% | +100.0% |
| Q2 2015 | $97,000 | -6.7% | 36,069 | +138.4% | 0.00% | -25.0% |
| Q1 2015 | $104,000 | – | 15,129 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 2,023,369 | $27,154,000 | 9.26% |
| Omega Fund Management, LLC | 551,477 | $7,401,000 | 5.46% |
| Foresite Capital Management III, LLC | 1,562,040 | $20,963,000 | 4.51% |
| Versant Venture Management, LLC | 1,048,601 | $14,072,225,000 | 4.39% |
| Boxer Capital, LLC | 2,094,000 | $28,101,000 | 3.18% |
| Opaleye Management Inc. | 697,500 | $9,360,000 | 2.42% |
| Abingworth LLP | 273,417 | $3,667,000 | 2.10% |
| DAFNA Capital Management LLC | 294,511 | $3,952,000 | 1.85% |
| NEXTHERA CAPITAL LP | 828,655 | $11,121,000 | 1.72% |
| Vivo Capital, LLC | 906,000 | $12,158,000 | 1.57% |